We are live on ! Find out more
LSBPW

LakeShore Biopharma Warrants
LSBPW

Delisted

LSBPW was delisted on the 19th of September, 2025.

Back to rankings

31 hedge funds and large institutions have $3.07M invested in LakeShore Biopharma Warrants in 2023 Q1 according to their latest regulatory filings, with 31 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
+31
Holders Change %
–
% of All Funds
0.49%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.05%
New
31
Increased
–
Reduced
–
Closed
–
Calls
$185K
Puts
–
Net Calls
+$185K
Net Calls Change
+$185K

Top Buyers

Rank Fund Capital Flow
1
LP
LMR Partners
United Kingdom
+$159K
2
VAM
Valliance Asset Management
Hong Kong
+$114K
3
BP
BFAM Partners
Hong Kong
+$83.3K
4
Jane Street
Jane Street
New York
+$75.5K
5
FC
Finepoint Capital
Massachusetts
+$74.2K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
1
LMR Partners
United Kingdom
$1.68M +$159K +1,052,461 New
SCM
2
Segantii Capital Management
Hong Kong
$320K +$30.3K +200,000 New
AC
3
Athos Capital
Hong Kong
$240K +$22.7K +149,999 New
VAM
4
Valliance Asset Management
Hong Kong
$117K +$114K +750,000 New
BP
5
BFAM Partners
Hong Kong
$85.6K +$83.3K +550,000 New
HCM
6
Highbridge Capital Management
New York
$84K – – –
SLM
7
Snow Lake Management
California
$77.8K +$75.8K +500,000 New
Jane Street
8
Jane Street
New York
$77.6K +$75.5K +498,301 New
FC
9
Finepoint Capital
Massachusetts
$76.3K +$74.2K +489,999 New
ICM
10
Ionic Capital Management
New York
$42.5K +$41.4K +273,169 New
BCL
11
Bracebridge Capital LLC
Massachusetts
$35.5K +$35.2K +232,323 New
Calamos Advisors
12
Calamos Advisors
Illinois
$22.7K +$22.1K +146,040 New
QGA
13
Q Global Advisors
Texas
$20K +$19.8K +130,600 New
WA
14
Whitebox Advisors
Minnesota
$19.5K +$18.9K +125,000 New
SCM
15
Shaolin Capital Management
Florida
$16K +$15.1K +99,766 New
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
$15.6K +$15.2K +100,000 New
ETH
17
Exos TFP Holdings
New York
$15.6K +$15.2K +100,000 New
PC
18
Periscope Capital
Ontario, Canada
$15.6K +$15.2K +100,000 New
RCM
19
Radcliffe Capital Management
Pennsylvania
$15.6K +$15.1K +99,900 New
Walleye Capital
20
Walleye Capital
New York
$15.6K +$15.1K +99,905 New
SCM
21
Saba Capital Management
New York
$15.2K +$14.7K +97,299 New
AA
22
AQR Arbitrage
Connecticut
$13.5K +$13.1K +86,625 New
CF
23
Cantor Fitzgerald
New York
$12K +$11.7K +76,931 New
CS
24
Clear Street
New York
$7.35K +$7.16K +47,225 New
SVI
25
Strategic Vision Investment
Hong Kong
$6.05K +$5.89K +38,857 New
1
2

LSBPW Hedge Fund Activity: Q1 2023 in Review

31 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in LakeShore Biopharma Warrants (LSBPW) for Q1 2023, worth a combined $3.07M.

Buyers outnumbered sellers: 31 funds opened new LSBPW positions and 0 closed out — a net gain of 31 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was LMR Partners, opening a new position worth an estimated $159K.

  • 31 institutional investors held LakeShore Biopharma Warrants (LSBPW) as of Q1 2023, up from 0 in Q4 2022.
  • Funds reported $3.07M of LakeShore Biopharma Warrants stock for Q1 2023.
  • 31 funds opened new LakeShore Biopharma Warrants positions in Q1 2023 and 0 closed out, a net change of +31 holders.
  • The largest LakeShore Biopharma Warrants buyer in Q1 2023 was LMR Partners, an estimated $159K added.

Based on aggregated 13F filings for Q1 2023.